Alpha IVF Group Berhad (KLSE: ALPHA)

Market Cap	1.70B
Revenue (ttm)	170.51M
Net Income (ttm)	54.65M
Shares Out	4.86B
EPS (ttm)	0.01
PE Ratio	30.06
Forward PE	25.93
Dividend	0.01 (2.61%)
Ex-Dividend Date	Jul 30, 2024

Volume	457,400
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.295 - 0.375
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 20, 2025

About Alpha IVF Group Berhad

Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia and Singapore. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization treatment, intra-cytoplasmic sperm injection, gamete intrafallopian transfer, and savior sibling program; preimplantation genetic testing; implantation optimisation; sperm sorting; and egg freezing, embryo freezing and c...

• Industry: Offices and Clinics of Doctors of Medicine
• Founded: 2011
• Employees: 150
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: ALPHA

Financial Performance

In 2024, Alpha IVF Group Berhad's revenue was 167.59 million, an increase of 21.90% compared to the previous year's 137.48 million. Earnings were 52.93 million, a decrease of -0.58%.